SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-19-004865
Filing Date
2019-03-26
Accepted
2019-03-26 16:36:02
Documents
70
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2018_soligenixinc.htm 10-K 996397
2 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT DATED AS OF APRIL 1, 2019 BETWEEN THE CO f10k2018ex10-30_soligenix.htm EX-10.30 17712
3 SUBSIDIARIES OF THE COMPANY f10k2018ex21-1_soligenix.htm EX-21.1 10049
4 CONSENT OF EISNERAMPER LLP f10k2018ex23-1_soligenix.htm EX-23.1 2786
5 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO EXCHANGE ACT RULE 13(A) f10k2018ex31-1_soligenix.htm EX-31.1 9772
6 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO EXCHANGE ACT RULE 13(A) f10k2018ex31-2_soligenix.htm EX-31.2 9834
7 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARB f10k2018ex32-1_soligenix.htm EX-32.1 3273
8 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARB f10k2018ex32-2_soligenix.htm EX-32.2 3260
9 GRAPHIC img_01.jpg GRAPHIC 817
10 GRAPHIC img_02.jpg GRAPHIC 800
  Complete submission text file 0001213900-19-004865.txt   4078656

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE sngx-20181231.xml EX-101.INS 584763
12 XBRL SCHEMA FILE sngx-20181231.xsd EX-101.SCH 48133
13 XBRL CALCULATION FILE sngx-20181231_cal.xml EX-101.CAL 56404
14 XBRL DEFINITION FILE sngx-20181231_def.xml EX-101.DEF 173336
15 XBRL LABEL FILE sngx-20181231_lab.xml EX-101.LAB 358646
16 XBRL PRESENTATION FILE sngx-20181231_pre.xml EX-101.PRE 269453
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14778 | Film No.: 19705680
SIC: 2834 Pharmaceutical Preparations